Accredo offers a wide range of medications to treat various complex and chronic conditions. Visit Conditions to learn more about treatment, medications, and support for your condition.
| Medication | Condition(s) | Generic/Biosimilar | Manufacturer |
|---|---|---|---|
| Xipere™ (triamcinolone acetonide injectable suspension) |
Macular edema associated with uveitis
|
Bausch Health, Inc. | |
| Xofigo® (radium Ra 223 dichloride) |
Prostate cancer
Symptomatic bone metastases
Visceral metastatic disease
|
Bayer HealthCare Pharmaceuticals | |
| Xolair® (omalizumab) – Enrollment Form |
Chronic idiopathic urticaria
|
Genentech, Inc. and Novartis Pharmaceuticals Corp. | |
| Xolair® (omalizumab) – Re-order Form (Existing Patients) | Genentech, Inc. and Novartis Pharmaceuticals Corp. | ||
| Xtandi® (enzalutamide) |
Prostate cancer
|
Astellas Pharma US, Inc. and Medivation, Inc. | |
| Xyntha™ [antihemophilic factor [recombinant], plasma/albumin_free) |
Congenital factor VIII deficiency
|
Pfizer, Inc. | |
| Xyrem® (sodium oxybate) |
Narcolepsy
|
Generic(s) Available | Jazz Pharmaceuticals, Inc. |
| Xywav™ (calcium, magnesium, potassium, and sodium oxybates) |
Narcolepsy
|
Jazz Pharmaceuticals, Inc. | |
| Ycanth™ (cantharidin) |
Molluscum Contagiosum
|
Verrica Pharmaceuticals | |
| Yervoy™ (ipilimumab) |
Melanoma
|
Bristol-Myers Squibb Company |